Literature DB >> 6327532

Serum antibody responses to the outer membrane proteins of Bordetella pertussis.

K Redhead.   

Abstract

The serum antibody responses to the outer membrane proteins, purified filamentous hemagglutinin, and leukocytosis-promoting factor of Bordetella pertussis were examined in mice and children immunized with pertussis whole-cell vaccine. It was found that, although there were many similarities in the responses of mice and children, there were important differences. Sera from vaccinated mice reacted strongly with purified filamentous hemagglutinin and gave weak or undetectable responses to the components of purified leukocytosis-promoting factor. The converse was found with sera from vaccinated children. Antibodies to leukocytosis-promoting factor may thus be of importance in protecting children against pertussis, although they appear to play no role in the active mouse protection test for vaccine efficacy. These results cast doubt on the value of the mouse as an animal model for the potency testing of extracted acellular pertussis vaccines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327532      PMCID: PMC263680          DOI: 10.1128/iai.44.3.724-729.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge.

Authors:  P L Kendrick; G Eldering; M K Dixon; J Misner
Journal:  Am J Public Health Nations Health       Date:  1947-07

2.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

3.  A simplified method for the quantitative assay of small amounts of protein in biologic material.

Authors:  G R Schacterle; R L Pollack
Journal:  Anal Biochem       Date:  1973-02       Impact factor: 3.365

4.  Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

Authors:  Y Sato; K Izumiya; H Sato; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

5.  Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.

Authors:  A Robinson; D C Hawkins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.

Authors:  M Pittman
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

7.  Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis.

Authors:  A C Wardlaw; R Parton; M J Hooker
Journal:  J Med Microbiol       Date:  1976-02       Impact factor: 2.472

8.  Current status of pertussis and pertussis vaccination in Finland.

Authors:  J Mertsola; M K Viljanen; O Ruuskanen
Journal:  Ann Clin Res       Date:  1982-12

9.  Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R L Cole
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  S I Morse; J H Morse
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  10 in total

1.  Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.

Authors:  J W Petersen; P H Ibsen; K Hasløv; I Heron
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine.

Authors:  S C Redd; H S Rumschlag; R J Biellik; G N Sanden; C B Reimer; M L Cohen
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  Immunization procedures for E. coli proteins.

Authors:  V R Anicetti; M A Simonetti; L L Blackwood; A J Jones; A B Chen
Journal:  Appl Biochem Biotechnol       Date:  1989-11       Impact factor: 2.926

Review 4.  The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

Authors:  N Halsey; A Galazka
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection.

Authors:  V J Rapp; R F Ross
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

6.  Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV).

Authors:  Yong-Zhang Zhu; Cheng-Song Cai; Wei Zhang; Hong-Xiong Guo; Jin-Ping Zhang; Ya-Yong Ji; Guang-Yuan Ma; Jia-Lin Wu; Qing-Tian Li; Cheng-Ping Lu; Xiao-Kui Guo
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

7.  Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.

Authors:  J W Petersen; A Holm; P H Ibsen; K Hasløv; C Capiau; I Heron
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Nitric oxide induction by pertussis toxin in mouse spleen cells via gamma interferon.

Authors:  S Sakurai; K Kamachi; T Konda; N Miyajima; M Kohase; S Yamamoto
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin.

Authors:  J W Petersen; A Holm; P H Ibsen; K Hasløv; I Heron
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli.

Authors:  D R Brown; C D Parker
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.